Lupus Research Institute, 23andMe, Pfizer Launch 5K-Patient Lupus Study | GenomeWeb

NEW YORK (GenomeWeb) – The Lupus Research Institute, 23andMe, and Pfizer today announced the launch of a 5,000-patient study to investigate the genetics of lupus.

23andMe announced it would conduct the longitudinal study in January as part of a broader collaboration with Pfizer to conduct genome-wide association studies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.